FDA Clears Biospace Med’s Revolutionary Low Dose Xray Imager
Oct 10th 2007Drug InformationBones
Biospace med announced that it has received 510k clearance from the Food and Drug Administration (FDA) to market EOS, a new digital Xray imager in the United States for 2D imaging use. EOS 2D|3D technology is part of a total solution to orthopedic imaging allowing images to be obtained with a low dose of radiation and is capable of long length digital imaging, permitting full-body, uninterrupted digital imaging with a single scan. [click link for full article]
More: continued here
No Comments »
Leave a Reply
You must be logged in to post a comment.
